Drug Shortages
Below is a list of current and anticipated ophthalmic drug shortages. This table is generated from Health Canada and is intended for use by practicing ophthalmologists. Drugs that have been out of production or unavailable for more than 12 months are not included in this table.
The table is updated daily.
Submission to Health Canada’s Consultation on Improving Access to Drugs and Other Health Products
Ophthalmic Essential Medication List for Canada
Last Updated: 2024-10-05 00:01:51
| Drug Name | Drug Status | Last Updated | DIN | Type | Anticipated Start Date | Estimated End Date | Actual Start Date | Actual End Date | Shortage Reason |
|---|---|---|---|---|---|---|---|---|---|
| MED-BRIMONIDINE | Marketed | 2020-12-09 | 02507811 | Shortage | 2022-08-01 | 2022-11-15 | 2022-08-08 | Demand increase for the drug. | |
| APO-OLOPATADINE | Marketed | 2024-03-09 | 02402823 | Shortage | 2024-03-26 | Disruption of the manufacture of the drug. | |||
| DIOFLUOR STRIPS | Marketed | 2023-11-16 | 02160773 | Shortage | 2020-12-01 | 2025-04-30 | 2021-03-22 | Disruption of the manufacture of the drug. | |
| ACT LATANOPROST/TIMOLOL | Marketed | 2024-02-09 | 02436256 | Shortage | 2021-08-27 | Disruption of the manufacture of the drug. | |||
| ATROPINE | Marketed | 2024-02-09 | 02023695 | Shortage | 2020-11-01 | Delay in shipping of the drug. | |||
| CYCLOGYL | Marketed | 2024-02-09 | 00252506 | Shortage | 2022-11-08 | 2024-06-30 | 2022-11-08 | Requirements related to complying with good manufacturing practices. | |
| JAMP-MOXIFLOXACIN | Marketed | 2024-03-09 | 02472120 | Shortage | 2024-10-04 | 2023-10-16 | Disruption of the manufacture of the drug. | ||
| JAMP-OLOPATADINE | Marketed | 2024-02-09 | 02458411 | Shortage | 2024-12-31 | 2023-08-24 | Other (Please describe in comments) | ||
| MIOCHOL-E | Marketed | 2021-12-08 | 02133326 | Shortage | 2024-08-05 | 2024-11-30 | Requirements related to complying with good manufacturing practices. | ||
| ODAN-TROPICAMIDE | Marketed | 2024-02-09 | 00622885 | Shortage | 2024-10-11 | 2024-04-22 | Disruption of the manufacture of the drug. | ||
| PDP-ERYTHROMYCIN | Marketed | 2020-04-03 | 01912755 | Shortage | 2024-09-30 | 2024-05-03 | Shortage of an inactive ingredient or component. | ||
| RESTASIS MULTIDOSE | Marketed | 2024-03-09 | 02476835 | Shortage | 2024-10-11 | 2024-11-15 | Other (Please describe in comments) | ||
| SANDOZ DORZOLAMIDE/TIMOLOL | Marketed | 2020-04-03 | 02344351 | Shortage | 2024-12-13 | 2024-07-08 | Requirements related to complying with good manufacturing practices. | ||
| TEVA-CYCLOSPORINE | Marketed | 2024-03-09 | 02462486 | Shortage | 2024-05-10 | Disruption of the manufacture of the drug. | |||
| TEVA-LATANOPROST | Marketed | 2024-02-09 | 02254786 | Shortage | 2025-04-30 | 2024-05-08 | Disruption of the manufacture of the drug. | ||
| TIMOLOL MALEATE-EX | Marketed | 2023-12-19 | 02242275 | Shortage | 2025-02-07 | 2024-05-13 | Disruption of the manufacture of the drug. | ||
| TIMOLOL MALEATE-EX | Marketed | 2023-12-19 | 02242276 | Shortage | 2025-02-07 | 2024-08-12 | Disruption of the manufacture of the drug. | ||
| TIMOPTIC | Marketed | 2024-03-09 | 00451207 | Shortage | 2024-06-17 | 2024-11-30 | 2024-06-17 | Demand increase for the drug. | |
| VISTITAN | Marketed | 2024-03-09 | 02429063 | Shortage | 2024-10-11 | 2024-09-30 | Disruption of the manufacture of the drug. |
